▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1422 by analyst upside · 2026-11-13
IRTC
iRhythm Holdings, Inc.
Healthcare · Market Cap $3B · P/E 0x
ANALYST PRICE TARGET
+66.4%
implied upside to consensus target
Current Price $93.56
Consensus Target $155.64
Bull Target $206.0
Bear Target $124.0
Analysts Covering 14
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
10
Hold
1
Sell
0
52-Week Low $82.85
52-Week High $192.47
YTD Return -46.6%
FUNDAMENTALS
Market Cap $3B
P/E Ratio (TTM) N/A
Forward P/E 59.8x
EPS (TTM) $-1.17
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $854M
Profit Margin -4.5%
52-WEEK RANGE
52-Week Low $82.85
52-Week High $192.47
Current Price $93.56
Bear Target $124.0
Bull Target $206.0
● Now $93.56 ● Target $155.64
TRADING DATA
Avg Volume 645K
YTD Return -46.6%
Analyst Count 14
Consensus Buy
Upside to Target +66.4%
Last Updated 2026-11-13

ANALYST SUMMARY

iRhythm Holdings, Inc. (IRTC) is currently trading at $93.56 with a Wall Street consensus price target of $155.64, implying potential upside of 66.4% over the next 12 months. 14 analysts currently cover IRTC, with a consensus rating of Buy - 93% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $206.0, while the most cautious has a target of $124.0.

IRTC operates in the Healthcare sector with a market capitalisation of $3B. The stock is down 46.6% year-to-date and is currently trading near the lower end of its 52-week range of $82.85 – $192.47.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for IRTC, with each firm's 90-day track record across all stocks we track. See full firm rankings →

JP Morgan - Reiterated
Overweight → Overweight 2026-11-07 43% win rate (7 calls)
Citigroup ↓ Downgrade
Buy → Neutral 2026-11-06 Building track record
Canaccord Genuity - Reiterated
Buy → Buy 2026-11-06 Building track record
Wells Fargo - Reiterated
Overweight → Overweight 2026-11-06 Building track record
Evercore ISI Group - Reiterated
Outperform → Outperform 2026-11-06 Building track record
Piper Sandler - Reiterated
Overweight → Overweight 2026-11-06 14% win rate (7 calls)
Needham - Reiterated
Buy → Buy 2026-11-06 20% win rate (5 calls)
BTIG - Reiterated
Buy → Buy 2026-11-06 38% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
55
out of 100
Coverage depth
21/30
Consensus clarity
12/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →